≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Cholera

EFO Endpoint Browser PheWeb

AB1_CHOLERA

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — A00
  • Hospital discharge: ICD-9 — 00[1]
  • Hospital discharge: ICD-8 — 00[0]
  • Cause of death: ICD-10 — A00
  • Cause of death: ICD-9 — 00[1]
  • Cause of death: ICD-8 — 00[0]

2 out of 7 registries used, show all original rules.

1603

4. Check minimum number of events

None

1603

5. Include endpoints

None

1603

6. Filter based on genotype QC (FinnGen only)

1603

Control definitions (FinnGen only)

Control exclude
AB1_INTESTINAL_INFECTIONS

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF5

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 16427 12352 3911
Only index persons 13094 10691 2403
Unadjusted period prevalence (%)
Whole population 0.29 0.35 0.11
Only index persons 0.34 0.39 0.09
Median age at first event (years)
Whole population 35.38 32.81 42.65
Only index persons 32.09 31.32 35.49

-FinnGen-

Key figures

All Female Male
Number of individuals 1603 1279 324
Unadjusted period prevalence (%) 0.38 0.44 0.14
Median age at first event (years) 31.56 29.62 39.23

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1516
Matched controls
15157
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
00000
ICD-8 Finland
NA
+∞
323.0
1474
*
R2110
NOMESCO Finland
Giving the first information
9.3
152.8
344
462
RF210
NOMESCO Finland
NA
14.8
124.9
217
169
XF400
NOMESCO Finland
ECG with 12 standard connections
4.5
114.4
486
1428
XF600
NOMESCO Finland
Bloodpressure measurement
7.9
109.5
270
405
WX002
NOMESCO Finland
Sedation and analgesia
3.3
77.1
502
2002
SPAT1212
SPAT
Extensive examination of musculoskeletal system
4.9
74.9
274
659
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.6
72.7
391
1337
RF220
NOMESCO Finland
NA
16.3
67.6
111
73
ZX120
NOMESCO Finland
Intravenous
4.4
65.4
266
706
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
5.3
64.5
214
458
62699
ICD-8 Finland
Disorders of menstruation, Other
6.7
52.2
140
228
WX408
NOMESCO Finland
General anesthesy, balanced
2.5
49.4
514
2598
ZXA00
NOMESCO Finland
Right side
2.4
48.4
564
3015
SPAT1315
SPAT
Periodic health check-up of children and adolescents
22.9
47.0
68
31
ZXA05
NOMESCO Finland
Left side
2.4
46.6
538
2852
R4120
NOMESCO Finland
Occupational therapy
3.9
40.3
178
498
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.2
39.9
562
3217
TKC20
NOMESCO Finland
Catheterisation of bladder
4.0
38.6
165
448
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
37.4
381
1855
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.5
37.4
352
1646
S44
ICPC
Skin, Preventive immunization/medic
10.5
37.3
74
74
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
4.6
36.9
134
311
64199
ICD-8 Finland
Abortion induced for other legal indications, Without mention of sepsis or toxaemia
3.0
35.5
232
872
SPAT1324
SPAT
Screening procedure
0.2
34.3
56
2027
SPAT1275
SPAT
Drug rehabilitation and replacement therapy of opioid-dependent person
32.3
33.6
44
14
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
32.2
707
4721
TLW99
NOMESCO Finland
Other minor surgical procedure in gynaecology
5.7
30.0
89
165
WVA40
NOMESCO Finland
Initiation and monitoring of intravenous hydration
10.7
29.3
57
55
R4110
NOMESCO Finland
Physiotherapy
2.0
28.5
470
2781
Y4308
ICD-8 Finland
Preventive sterilization, Legal preventive sterilization performed for other reasons
6.1
27.8
77
131
WX320
NOMESCO Finland
Spinalanesthesy
2.1
27.7
399
2234
SEMI
NOMESCO Finland
NA
13.0
27.2
48
38
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.0
26.7
471
2845
PUHSE
NOMESCO Finland
NA
46.6
26.5
32
7
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
2.0
25.9
426
2501
HMAK
NOMESCO Finland
NA
2.5
25.4
224
992
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
16.0
24.2
39
25
RF310
NOMESCO Finland
NA
21.0
23.9
35
17
P19
ICPC
Drug abuse
27.2
23.6
32
12
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.5
23.4
196
844
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.9
23.3
99
266
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.9
22.7
456
2854
WX110
NOMESCO Finland
Local anesthesy
1.7
22.4
994
7940
M79.6
ICD-10 Finland
Pain in limb
1.7
21.0
569
3900
SPAT1249
SPAT
Treatment-related counselling outside office
1.7
20.9
600
4187
SPAT1245
SPAT
Provision of support and information to patient’s family members
3.7
20.7
93
263
SPAT1307
SPAT
Psychosocial counselling and guidance
3.9
19.9
83
220
WX892
NOMESCO Finland
Monitored bed care
2.8
19.7
131
492
N02AX02
ATC
tramadol; systemic, rectal
1.7
19.5
642
4626
61200
ICD-8 Finland
NA
11.5
19.5
36
32
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.4
19.2
182
831
SPAT1379
SPAT
Health check-up of pregnant person
10.2
18.4
36
36
M53.3
ICD-10 Finland
Sacrococcygeal disorders, not elsewhere classified
9.5
18.2
37
40
H02AB07
ATC
prednisone; oral
2.0
17.8
251
1366
SPAT1262
SPAT
Handing over of treatment supplies
1.9
17.7
279
1586
65000
ICD-8 Finland
Delivery without mention of complication, Occipital presentation
1.6
17.6
653
4822
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
17.2
323
1949
SPAT1325
SPAT
Vaccination
1.7
17.1
521
3641
Z71.8
ICD-10 Finland
Other specified counselling
1.8
17.0
340
2095
LC2HE
NOMESCO Finland
Hystero-salpingography with ultrasound
3.2
16.8
89
288
SPAT1255
SPAT
Intravenous administration of medicine
2.8
16.7
111
417
I20.00
ICD-10 Finland
Unstable angina
4.2
16.6
64
159
55099
ICD-8 Finland
Inguinal hernia without mention of obstruction
3.9
16.5
69
184
WX882
NOMESCO Finland
High dependency care
4.3
16.5
62
150
F2680
NOMESCO Finland
NA
40.5
16.3
20
5
R83
ICPC
Respiratory infection other
0.4
16.3
77
1754
XJC00
NOMESCO Finland
Oesophageal manometry
11.3
16.3
30
27
WVA20
NOMESCO Finland
Medicine administration
4.7
16.1
55
121
A67
ICPC
General and Unspecified, Referral to physician/hospital
18.7
16.0
24
13
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.7
16.0
449
3056
C01DA14
ATC
isosorbide mononitrate; oral
2.0
15.9
226
1231
Z00.1
ICD-10 Finland
Routine child health examination
33.7
15.7
20
6
SPAT1281
SPAT
Other administrative function
2.4
15.6
131
564
G04AB05
ATC
NA
3.4
15.5
77
238
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
15.4
299
1817
SPAT1248
SPAT
OTHER EXAMINATIONS, PROCEDURES, TREATMENT ETC.
14.9
15.4
25
17
J01FA09
ATC
clarithromycin; systemic
1.6
15.4
489
3436
M53.8
ICD-10 Finland
Other specified dorsopathies
11.4
15.3
28
25
WX722
NOMESCO Finland
PEEP
3.2
15.2
82
269
56500
ICD-8 Finland
Anal fissure and fistula, Anal fissure
7.9
15.1
34
44
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.3
15.1
151
708
8501
FHL
Emptying the uterus with suction
4.8
15.0
50
108
UJF32
NOMESCO Finland
Coloscopy
1.7
14.8
397
2657
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
14.8
492
3490
J01DA06
ATC
[U] cefuroxime; systemic
1.9
14.6
240
1375
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.8
14.5
297
1831
M03BC01
ATC
orphenadrine (citrate); systemic
1.7
14.5
339
2178
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
7.6
14.4
33
44
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.2
14.2
143
672
R5140
NOMESCO Finland
Monitoring the use of the aid
2.1
14.1
158
779
TJK01
NOMESCO Finland
Laparoscopic cholangiography
6.9
13.9
34
50
RF230
NOMESCO Finland
NA
30.3
13.9
18
6
J45
ICD-10 Finland
Asthma
2.1
13.9
163
821
NB2AT
NOMESCO Finland
Intra artrial injection of shoulder with ultrasound guidance
5.5
13.8
40
74
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
13.7
404
2762
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.0
13.6
184
980
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
2.7
13.6
95
366
A00.9
ICD-10 Finland
Cholera, unspecified
+∞
13.6
13
*
F2682
NOMESCO Finland
NA
34.3
13.5
17
5
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
13.2
397
2727
C09AA04
ATC
perindopril; oral
2.6
13.1
94
371
J01DA08
ATC
[U] cefaclor; oral
2.1
13.1
149
740
RF120
NOMESCO Finland
NA
5.8
13.0
36
63
A02BC02
ATC
pantoprazole; systemic
1.5
13.0
979
8288
FN1AT
NOMESCO Finland
Endovascular dilatation of coronary arteries (PTCA)
3.1
12.9
70
232
6452
FHL
Sphincterotomy
14.2
12.8
21
15
J34.3
ICD-10 Finland
Hypertrophy of nasal turbinates
4.9
12.7
41
86
1DA08
NOMESCO Finland
NA
70.5
12.6
14
*
SPAT1094
SPAT
Continuous Positive Airway Pressure
6.7
12.5
31
47
73791
ICD-8 Finland
NA
+∞
12.5
12
*
A00.0
ICD-10 Finland
Cholera due to Vibrio cholerae 01, biovar cholerae
+∞
12.5
12
*
00920
ICD-8 Finland
Diarrhoeal disease, Gastroenteritis (acuta) (infectiosa)
+∞
12.5
12
*
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
12.5
264
1639
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.3
12.4
115
517
A02BC01
ATC
omeprazole; systemic
1.6
12.4
418
2948
XJ110
NOMESCO Finland
Respiratory helicobactery test
14.5
12.3
20
14
SPAT1042
SPAT
Guidance concerning balance maintenance
9.1
12.2
25
28
B01AC04
ATC
clopidogrel; oral
1.8
12.2
211
1226
WX402
NOMESCO Finland
General anaesthesia
1.8
12.2
229
1366
NG1EA
NOMESCO Finland
Knee X-ray examination with wrench
4.5
12.0
42
96
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.3
11.9
109
487
ZX114
NOMESCO Finland
Intramuscular
5.0
11.9
37
75
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.6
11.9
85
334
SPAT1240
SPAT
Therapeutic discussion
2.1
11.8
129
629
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
14.8
11.8
19
13
ZX100
NOMESCO Finland
Oral
5.0
11.4
36
74
DHB50
NOMESCO Finland
Turbinoplasty
4.0
11.4
45
116
R03DC03
ATC
montelukast; oral
1.7
11.4
241
1493
78559
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD
2.6
11.2
79
309
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
11.2
648
5124
RF223
NOMESCO Finland
NA
25.2
11.1
15
6
M01AB05
ATC
diclofenac; systemic, rectal
1.5
11.1
961
8224
A04.8
ICD-10 Finland
Other specified bacterial intestinal infections
8.1
11.1
24
30
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
0.6
11.0
234
3457
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
2.7
10.9
76
294
I25.5
ICD-10 Finland
Ischaemic cardiomyopathy
5.3
10.9
32
61
54090
ICD-8 Finland
Acute appendicitis, Phlegmonosa, peritonitide non indicata
5.3
10.9
32
61
TQW99
NOMESCO Finland
Other minor procedure on skin
2.4
10.8
94
409
XKD00
NOMESCO Finland
Uroflowmetry
1.9
10.8
158
863
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.7
10.8
230
1428
M54.5
ICD-10 Finland
Low back pain
1.5
10.6
444
3271
M02AA15
ATC
diclofenac; topical (antiinflammatory prep., non-steroids for topical use)
2.0
10.6
135
703
XJC10
NOMESCO Finland
Oesophageal pH monitoring
9.2
10.5
21
23
A02BC05
ATC
esomeprazole; systemic
1.5
10.5
598
4693
D19
ICPC
Teeth/gum symptom/complaint
1.5
10.4
362
2554
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.7
10.4
70
267
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
10.4
252
1622
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
6.1
10.3
27
45
F1246
NOMESCO Finland
NA
23.5
10.2
14
6
J01FA06
ATC
roxithromycin; oral
1.4
10.2
607
4794
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.8
10.2
190
1133
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
5.5
10.1
29
54
-60
ICPC
Result test/procedure
0.2
10.1
9
470
B01AB05
ATC
enoxaparin; parenteral
1.5
10.0
444
3302
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.2
10.0
50
158
RF232
NOMESCO Finland
NA
40.3
10.0
12
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.8
9.9
171
994
I25
ICD-10 Finland
Chronic ischaemic heart disease
2.6
9.9
71
282
XG405
NOMESCO Finland
Education on PEF monitoring
4.6
9.9
33
73
J01MA06
ATC
norfloxacin; oral
1.7
9.9
226
1431
D82
ICPC
Teeth/gum disease
0.6
9.9
234
3389
WX419
NOMESCO Finland
Other general anesthesy
5.5
9.8
28
52
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.8
9.8
61
222
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
9.7
500
3833
62550
ICD-8 Finland
NA
4.8
9.7
31
66
SFA00
NOMESCO Finland
Small filling
1.8
9.6
187
1127
M03BC51
ATC
orphenadrine, combinations; systemic
1.5
9.6
414
3058
C50.99
ICD-10 Finland
Breast, unspecified
2.6
9.6
66
257
M01AB55
ATC
diclofenac, combinations; oral
2.0
9.6
123
642
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.0
9.6
129
686
HSOP
NOMESCO Finland
NA
11.4
9.6
17
15
SPAT1097
SPAT
Recording of ECG
0.5
9.6
68
1352
W78
ICPC
Pregnancy
5.7
9.5
26
46
SPAT1383
SPAT
Extensive health check-up at 4 years of age
30.2
9.4
12
*
SPAT1064
SPAT
Management of tracheostomy stoma
30.2
9.4
12
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
9.4
305
2114
TKD00
NOMESCO Finland
Dilatation of urethra
6.2
9.4
24
39
P24
ICPC
Specific learning problem
+∞
9.4
9
*
RT162
NOMESCO Finland
NA
+∞
9.4
9
*
RT161
NOMESCO Finland
NA
+∞
9.4
9
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.8
9.3
171
1013
63495
ICD-8 Finland
Other complications of pregnancy, Effluxus liquoris amnii praetemporarius
6.5
9.3
23
36
C07AB07
ATC
bisoprolol; oral
1.4
9.2
678
5539
A29
ICPC
General symptom/complaint other
0.4
9.2
41
960
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.0
9.1
113
583
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.8
9.1
151
866
M01AX17
ATC
nimesulide; oral
1.5
9.0
390
2877
0
NOMESCO Finland
NA
15.7
9.0
14
9
SPAT1193
SPAT
Pap smear
0.3
9.0
21
649
R06AX27
ATC
desloratadine; oral
1.5
8.9
349
2516
TAC99
NOMESCO Finland
Other blockade for chronic pain
6.1
8.9
23
38
LCA06
NOMESCO Finland
Biopsy of endometrium
1.7
8.9
212
1354
SPAT1303
SPAT
Counselling and guidance related to growth and development
24.2
8.9
12
5
XF404
NOMESCO Finland
Ambulatory ECG
1.9
8.8
138
774
R07.3
ICD-10 Finland
Other chest pain
1.9
8.8
136
760
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
2.3
8.8
81
367
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.6
8.7
237
1567
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.2
8.7
88
416
F8109
NOMESCO Finland
NA
50.3
8.7
10
*
F1784
NOMESCO Finland
NA
50.3
8.7
10
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
0.2
8.7
8
406
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
8.7
158
933
QAB00
NOMESCO Finland
Suture of skin of head or neck
5.1
8.6
26
52
45499
ICD-8 Finland
Varicose veins of lower extremities, Other and unspecified, without ulcer
1.9
8.6
120
646
VALMI
NOMESCO Finland
NA
1.5
8.6
318
2263
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.8
8.6
156
919
21900
ICD-8 Finland
Other benign neoplasm of uterus, Papiloma, polyp
3.9
8.6
33
85
ZXA10
NOMESCO Finland
Bilateral
1.6
8.5
272
1872
R03BB01
ATC
ipratropium bromide; inhalant
2.4
8.5
68
286
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.5
8.5
66
275
P01AB01
ATC
metronidazole; oral, rectal
1.4
8.5
580
4654
RT120
NOMESCO Finland
NA
20.1
8.5
12
6
S33.6
ICD-10 Finland
Sprain and strain of sacroiliac joint
20.1
8.5
12
6
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.6
8.5
257
1747
I20.09
ICD-10 Finland
Unstable angina
2.2
8.4
79
362
XX3DW
NOMESCO Finland
Time consuming IT work
0.4
8.4
38
886
J02AC01
ATC
fluconazole; systemic
1.4
8.4
617
5018
C08CA07
ATC
nisoldipine; oral
4.5
8.4
28
63
0088X
ICD-9 Finland
Intestinal infections due to other organisms, Other organism, not elsewhere classified
+∞
8.3
8
*
KMAK
NOMESCO Finland
NA
1.4
8.3
664
5474
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.5
8.3
272
1885
62660
ICD-8 Finland
Disorders of menstruation, Intermenstrual bleeding
2.5
8.2
63
259
UJD02
NOMESCO Finland
Gastroscopy
2.3
8.2
77
350
Z97.4
ICD-10 Finland
Presence of external hearing-aid
2.3
8.2
75
341
UKC02
NOMESCO Finland
Cystoscopy
1.6
8.2
194
1240
XG420
NOMESCO Finland
Time-volume spirometry
33.5
8.1
10
*
8511
FHL
Cervical dilation and drainage with suction
2.3
8.1
76
347
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.8
8.1
141
823
6266A
ICD-9 Finland
Disorders of menstruation and other abnormal bleeding from female genital tract, Metrorrhagia
2.2
8.1
77
357
SPAT1099
SPAT
Measurement of blood pressure with Doppler ultrasound device
2.7
8.0
52
196
64594
ICD-8 Finland
Other abortion, Retentio ovi (partialis)
3.0
8.0
46
159
A97
ICPC
No disease
1.6
8.0
194
1242
RD112
NOMESCO Finland
NA
22.1
8.0
11
5
J01MA02
ATC
ciprofloxacin; systemic
1.4
7.9
502
3967
R53
ICD-10 Finland
Malaise and fatigue
1.5
7.9
258
1783
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.1
7.9
82
393
N06AA06
ATC
trimipramine; systemic
3.0
7.8
42
141
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.2
7.8
80
382
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.9
7.8
45
157
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.5
7.8
57
230
S01BA04
ATC
prednisolone; ophthalmic (corticosteroids, plain)
2.9
7.8
45
158
M03BX02
ATC
tizanidine; oral
1.4
7.8
865
7496
63496
ICD-8 Finland
Other complications of pregnancy, Labores inhibiti
3.1
7.8
40
131
M02AA07
ATC
piroxicam; topical
1.4
7.7
559
4512
N30.9
ICD-10 Finland
Cystitis, unspecified
2.1
7.7
88
439
RF124
NOMESCO Finland
NA
45.2
7.7
9
*
TPH07
NOMESCO Finland
Cathetrisation of artery
1.8
7.7
134
780
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.0
7.7
92
468
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.3
7.7
71
323
C03CA01
ATC
furosemide; systemic
1.4
7.7
389
2947
XLA10
NOMESCO Finland
NA
2.0
7.7
94
482
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
2.8
7.6
47
173
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.7
7.6
50
191
SPAT1063
SPAT
Suctioning of mucus from airways
18.4
7.6
11
6
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
2.0
7.6
90
458
R99
ICPC
Respiratory disease other
3.5
7.6
33
95
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
3.8
7.6
30
80
SPAT1308
SPAT
Sexual health counselling
2.8
7.5
48
178
R01AD09
ATC
mometasone; nasal
1.4
7.5
607
4986
M01AH02
ATC
rofecoxib; oral
1.6
7.5
218
1464
R03BA02
ATC
budesonide; inhalant
1.5
7.5
238
1636
R03AC02
ATC
salbutamol; inhalant
1.3
7.5
720
6084
XA420
NOMESCO Finland
Extensive sleep examination
4.4
7.5
25
57
P22
ICPC
Child behaviour symptom/complaint
80.5
7.4
8
*
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.0
7.4
90
461
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.5
7.4
263
1854
R06AE07
ATC
cetirizine; oral
1.4
7.4
598
4913
C10AA07
ATC
rosuvastatin; oral
1.4
7.3
355
2666
RT350
NOMESCO Finland
NA
15.8
7.2
11
7
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.9
7.2
105
577
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
2.3
7.2
60
262
RT274
NOMESCO Finland
NA
20.1
7.1
10
5
5CM18
NOMESCO Finland
NA
20.1
7.1
10
5
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
7.1
283
2041
TQB05
NOMESCO Finland
Puncture of skin of trunk
5.1
7.1
21
42
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
7.1
165
1047
K04
ICPC
Palpitations/awareness of heart
0.3
7.1
11
416
JN4BD
NOMESCO Finland
Extensive body CT
1.7
7.1
152
942
B04AC04
ATC
NA
8.8
7.0
14
16
72410
ICD-8 Finland
Internal derangement of joint, Other shoulder derangement
2.8
7.0
42
152
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
4.0
7.0
26
66
64595
ICD-8 Finland
Other abortion, Haemorrhagia post abortum NUD
5.2
6.9
20
39
XX3XW
NOMESCO Finland
NA
7.6
6.9
15
20
SPAT1254
SPAT
Administration of medicine
1.6
6.9
181
1188
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
6.9
175
1139
LGA21
NOMESCO Finland
Laparoscopic sterilisation by constriction of Fallopian tubes
1.9
6.8
94
506
XJH10
NOMESCO Finland
Anorectal manometry
8.3
6.8
14
17
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.4
6.8
389
3005
RT172
NOMESCO Finland
NA
40.2
6.8
8
*
H25.8
ICD-10 Finland
Other senile cataract
0.5
6.7
53
1016
Z76
ICD-10 Finland
Persons encountering health services in other circumstances
3.8
6.7
26
69
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
6.6
111
639
R03AC03
ATC
terbutaline; inhalant
1.6
6.6
193
1298
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.8
6.6
100
558
K29.3
ICD-10 Finland
Chronic superficial gastritis
2.4
6.6
53
226
1210
FHL
Anthroscopy
8.7
6.6
13
15
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.1
6.5
68
326
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
6.5
188
1261
RT272
NOMESCO Finland
NA
10.1
6.5
12
12
8115
FHL
Laparoscenes (including Douglas)
6.9
6.5
15
22
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.5
6.5
257
1850
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.5
6.5
196
1328
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
0.6
6.5
76
1305
J06
ICD-10 Finland
Acute upper respiratory infections of multiple and unspecified sites
3.0
6.5
35
120
A02BC03
ATC
lansoprazole; oral
1.4
6.5
424
3348
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.6
6.4
149
943
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
0.4
6.4
25
617
RT360
NOMESCO Finland
NA
70.1
6.4
7
*
A00
ICD-10 Finland
Cholera
70.1
6.4
7
*
TKC22
NOMESCO Finland
Catheterisation instruction
3.5
6.4
28
82
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.7
6.4
121
724
A12BA01
ATC
potassium chloride; oral
2.1
6.4
67
324
TNX99
NOMESCO Finland
Other orthopaedic minor procedure
2.5
6.3
48
198
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
4.6
6.3
20
44
J01DA01
ATC
[U] cefalexin; systemic
1.3
6.3
867
7641
8113
FHL
Fractional scraping
1.7
6.3
125
761
SPAT1386
SPAT
Extensive health check-up on eighth grade
+∞
6.3
6
*
0092A
ICD-9 Finland
Ill-defined intestinal infections, Infectious diarrhoea
+∞
6.3
6
*
R43
ICPC
Respiratory, Other diagnostic procedure
4.3
6.2
21
49
SPAT1321
SPAT
Health examination of person liable for military service
26.8
6.2
8
*
RF312
NOMESCO Finland
NA
26.8
6.2
8
*
UJF30
NOMESCO Finland
Ileoscopy through colon
0.5
6.1
36
760
TND32
NOMESCO Finland
Custom moulded splint, wrist or hand
3.4
6.1
27
80
A23
ICPC
Risk factor NOS
0.4
6.1
18
499
WX203
NOMESCO Finland
Infraclavicular plexus blockade
2.7
6.1
40
153
R05
ICPC
Cough
0.7
6.1
151
2186
R4190
NOMESCO Finland
Nutritional therapy
2.5
6.1
45
186
R05
ICD-10 Finland
Cough
1.5
6.1
253
1839
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
3.7
6.1
24
65
TUPEI
NOMESCO Finland
NA
0.1
6.1
*
232
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.6
6.1
162
1067
AA1AD
NOMESCO Finland
CT of head and brain
1.4
6.0
306
2308

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3033658) Prothrombin time (PT) actual/Normal
816
3279
4.03
165.71
5.3
3.6
%
91.9
92.7
0.39
811
3178
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
589
2021
4.03
147.27
3.5
2.7
e6/l
3.3
3.1
0.16
351
1060
(36304419) Bacteria [Presence] in Urine
774
3439
3.42
126.44
4.6
2.9
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
580
2189
3.58
122.41
3.5
2.6
e6/l
0.9
1.2
1.32
347
1223
(3030467) Casts [#/volume] in Urine by Automated count
775
3556
3.28
118.06
4.6
3.0
e6/l
0.3
0.5
1.05
546
2655
(3002582) Erythrocytes [#/volume] in Urine
794
3827
3.13
108.88
4.6
3.1
e6/l
27.9
73.4
1.70
564
2893
(3026782) Osmolality of Urine
578
2463
3.11
96.04
3.2
2.7
mosm/kgh2o
541.5
527.5
0.90
460
2071
(3018095) Leukocytes [#/volume] in Urine
833
4556
2.72
83.80
5.3
3.6
e6/l
140.7
118.7
0.12
578
3158
(3014051) Protein [Presence] in Urine by Test strip
172
346
5.45
82.27
2.0
2.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
568
2662
2.76
76.06
3.2
2.5
e6/l
5.3
6.2
0.86
453
2305
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
532
2525
2.66
68.21
4.1
3.5
ng/l
235.1
320.4
0.38
435
1977
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
353
1460
2.82
58.21
3.4
2.5
umol/l
7.4
7.9
0.22
332
1257
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
308
1207
2.92
55.99
2.8
2.2
u/l
46.6
40.2
0.24
266
1035
(3006462) Nitrate [Presence] in Urine
55
49
11.59
52.86
2.0
4.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
149
396
4.05
49.99
3.5
3.2
—
—
—
0
0
(4211845)
55
56
10.13
48.25
2.0
3.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
192
643
3.26
45.39
2.0
2.0
—
—
—
0
0
(3000492) Spirometry study
274
1122
2.74
45.18
1.7
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
593
3461
2.13
43.46
7.9
6.6
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
102
245
4.38
39.02
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
102
245
4.38
39.02
1.3
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
221
904
2.68
36.07
2.8
3.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
229
976
2.57
34.31
7.9
7.7
—
—
—
0
0
(3018418) pH of Serum or Plasma
641
4221
1.86
30.57
4.4
3.7
ph
7.4
7.4
1.05
50
790
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
168
655
2.75
29.93
8.1
8.8
mmol/l
24.4
24.7
0.46
163
608
(3000330) Specific gravity of Urine by Test strip
183
754
2.61
29.20
2.2
3.5
—
—
—
0
0
(3044889) 12 lead EKG panel
1208
9781
1.95
28.74
4.2
3.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
45
1848
0.22
26.05
3.9
4.7
%
36.6
33.2
1.90
29
1185
(3009542) Hematocrit [Volume Fraction] of Blood
1366
11689
2.14
25.88
24.4
14.9
%
40.0
38.8
11.12
1276
7902
(3013512) EKG study
237
4244
0.48
23.79
3.0
3.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
789
5817
1.70
23.58
9.0
9.2
e9/l
0.0
0.0
0.23
540
4742
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
54
1826
0.27
22.30
7.9
6.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
262
1408
2.03
22.00
1.6
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
261
1416
2.01
21.30
1.6
1.7
—
—
—
0
0
(3019225) pH of Specimen
35
1476
0.22
20.82
3.5
4.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
24
25
9.73
20.58
1.2
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
148
3003
0.44
20.40
1.7
1.7
pmol/l
451.7
24897401.5
2.21
129
2426
(3024891) Influenza virus A+B Ag [Presence] in Specimen
82
266
3.19
20.23
1.2
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
479
3189
1.72
20.10
3.0
3.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
198
991
2.14
20.02
1.3
1.2
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
24
7
34.77
18.92
1.2
1.4
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
42
91
4.71
18.27
1.4
1.1
titre
104.0
81.9
—
5
16
(4094501)
98
373
2.73
18.19
1.1
1.1
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
98
375
2.72
18.00
3.8
2.3
g/l
0.0
0.0
0.00
92
349
(40768804) Tissue Pathology biopsy report
756
5770
1.59
17.87
2.3
2.1
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
98
378
2.70
17.73
3.8
2.3
g/l
0.0
0.0
0.00
92
350
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
100
404
2.57
16.50
3.8
2.2
g/l
0.1
0.0
0.47
94
374
(42870588) Differential panel, method unspecified - Blood
599
4415
1.57
15.93
6.7
5.6
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
758
5914
1.53
15.45
7.4
5.7
%
0.7
0.7
0.12
649
5470
(3018010) Neutrophils/100 leukocytes in Blood
780
6150
1.52
14.97
7.2
5.6
%
56.7
56.7
0.00
672
5707
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
115
521
2.30
14.78
1.1
1.1
—
0.9
—
0
5
(44806420)
23
35
6.65
14.49
1.3
2.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
84
335
2.59
14.24
1.1
1.1
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
766
6068
1.50
14.05
7.3
5.7
%
2.9
2.9
0.35
659
5608
(42529406) Shigella sp [Presence] in Stool by Culture
84
338
2.57
13.99
1.1
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
355
2373
1.64
13.92
1.5
1.4
g/l
2.6
2.4
0.26
139
1370
(3026493) Urate [Moles/volume] in Serum or Plasma
470
3365
1.56
13.78
2.8
2.4
umol/l
2777.2
5965.8
1.00
296
2864
(3019069) Monocytes/100 leukocytes in Blood
766
6097
1.49
13.55
7.4
5.9
%
8.7
8.6
0.15
659
5660
(3002030) Lymphocytes/100 leukocytes in Blood
781
6243
1.49
13.51
7.3
5.8
%
28.6
28.4
0.20
673
5760
(3012095) Magnesium [Moles/volume] in Serum or Plasma
321
2111
1.65
13.37
3.5
3.1
mmol/l
0.8
0.8
1.71
310
1943
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
145
749
2.03
13.36
1.4
1.6
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
101
452
2.32
13.36
3.8
2.4
g/l
0.7
0.8
0.20
94
394
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
563
4237
1.51
12.94
3.5
3.1
u/l
32.2
35.7
0.69
553
4014
(3044640) Blood type and Crossmatch panel - Blood
555
4188
1.50
12.49
2.4
2.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
372
5137
0.64
12.39
3.2
3.4
ng/l
224.3
40.1
0.50
245
3563
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1395
12731
1.74
12.35
18.8
13.0
ml/min/173m2
78.3
77.0
1.67
1152
10474
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
127
646
2.05
12.20
8.9
9.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
714
5693
1.46
12.02
2.2
2.0
pmol/l
95.7
96.5
0.11
230
2701
(3018677) aPTT in Platelet poor plasma by Coagulation assay
289
1900
1.64
11.94
1.8
1.9
s
29.8
29.3
0.91
289
1842
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
439
3180
1.52
11.91
2.3
2.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
49
161
3.11
11.91
1.1
1.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
291
1926
1.62
11.68
2.4
2.2
umol/l
12.3
13.0
1.16
284
1767
(3029937) Albumin [Presence] in Urine by Test strip
233
3512
0.61
11.13
3.8
4.2
estimate
0.0
0.0
0.69
79
1142
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
65
259
2.57
11.09
1.2
1.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
102
496
2.13
11.05
3.7
2.4
g/l
3.2
3.2
0.14
96
388
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
77
333
2.38
11.04
1.2
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
223
3385
0.60
10.94
3.4
3.6
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
35
99
3.59
10.78
2.4
1.5
u/l
2.6
8.1
1.52
27
46
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
380
2725
1.52
10.64
3.1
3.0
mmol/l
2.5
2.5
0.90
252
2408
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
777
6391
1.42
10.56
6.0
5.2
mmol/l
1.2
1.2
1.07
752
5749
(3013115) Eosinophils [#/volume] in Blood
812
6754
1.41
10.23
7.4
5.7
e9/l
0.2
0.2
1.39
711
5877
(3004789) Transferrin [Mass/volume] in Serum or Plasma
265
1767
1.60
10.22
2.3
2.2
g/l
2.4
2.4
0.06
259
1627
(3025130) Human papilloma virus identified in Specimen
46
160
2.93
10.17
1.7
1.8
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
250
1653
1.61
9.98
5.3
4.4
mmol/l
1.0
1.0
0.11
233
1509
(3019198) Lymphocytes [#/volume] in Blood
798
6637
1.40
9.95
7.2
5.6
e9/l
2.1
1.9
0.86
702
5809
(3001604) Monocytes [#/volume] in Blood
781
6481
1.40
9.82
7.3
5.5
e9/l
0.6
0.6
1.68
573
5547
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
103
530
2.01
9.61
3.7
2.3
g/l
7.4
7.6
0.33
96
397
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
103
530
2.01
9.61
3.7
2.3
g/l
3.7
3.7
0.24
96
379
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
103
530
2.01
9.61
3.7
2.3
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
781
6509
1.39
9.43
7.3
5.5
e9/l
0.0
0.0
0.59
576
5585
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
28
77
3.68
9.01
2.2
2.0
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
179
1118
1.68
8.92
3.6
3.1
ng/l
80.5
80.6
0.01
172
947
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
33
102
3.28
8.92
1.4
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
220
1454
1.59
8.75
2.4
2.0
ug/g
89.2
128.9
2.40
198
1133
(3013650) Neutrophils [#/volume] in Blood by Automated count
896
7693
1.37
8.73
11.0
9.0
e9/l
4.1
3.9
1.19
673
6696
(4198724)
13
19
6.89
8.45
1.0
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
101
541
1.93
8.42
1.3
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
133
783
1.76
8.21
1.7
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
437
3362
1.41
8.20
4.9
4.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
63
287
2.24
8.08
1.4
1.3
iu/l
47.3
42.5
0.48
51
241
(40760892) CBC W Ordered Manual Differential panel - Blood
182
2720
0.63
8.04
3.7
4.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
284
2024
1.49
7.98
1.6
1.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
554
4469
1.37
7.72
3.7
3.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
76
383
2.03
7.56
2.7
3.3
u/ml
0.3
0.4
2.95
40
224
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
96
526
1.88
7.50
1.8
1.7
g/l
1.4
1.6
1.03
76
462
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
97
535
1.87
7.43
4.2
3.5
u/ml
662.9
722.3
0.04
83
460
(3003694) ABO and Rh group [Type] in Blood
413
3194
1.39
7.40
1.3
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
59
273
2.21
7.32
1.3
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
19
46
4.17
7.28
1.4
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
55
1126
0.47
7.26
2.6
3.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
167
1083
1.61
7.17
2.1
2.7
ng/l
202.0
187.3
0.20
152
983
(3024561) Albumin [Mass/volume] in Serum or Plasma
705
5953
1.33
7.08
5.3
4.2
g/l
35.5
35.5
0.02
678
5512
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
59
277
2.17
7.07
2.6
2.4
ug/min
46.7
56.4
0.13
39
166
(3027801) Oxygen [Partial pressure] in Arterial blood
208
1428
1.52
6.95
7.3
6.7
kpa
12.5
12.3
0.14
201
1366
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
208
1428
1.52
6.95
7.3
6.7
kpa
5.1
5.1
0.63
202
1370
(40768797) Stomach Pathology biopsy report
270
1958
1.46
6.89
1.3
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
815
7051
1.32
6.79
2.5
2.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
51
1046
0.47
6.77
4.8
3.7
%
0.6
0.6
—
5
221
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
14
520
0.26
6.71
2.2
1.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
359
2753
1.39
6.69
1.3
1.2
u/ml
1.8
1.8
0.04
44
713
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
12
473
0.25
6.38
2.5
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
402
4983
0.74
6.13
3.3
4.1
—
—
—
0
0
(3002256) Pathology report gross observation
253
1851
1.44
6.12
1.3
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
61
1138
0.52
6.11
4.9
3.9
%
1.0
1.0
—
6
298
(3007930) Methemoglobin/Hemoglobin.total in Blood
14
491
0.28
6.09
5.6
4.9
%
0.9
0.9
0.27
14
460
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
34
134
2.57
6.05
2.7
3.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1015
9143
1.30
5.86
4.9
4.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
59
1095
0.52
5.82
5.0
4.0
%
0.2
0.1
—
5
275
(46235355) HIV 1 and 2 tests - Meaningful Use set
176
1212
1.51
5.79
1.4
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
17
519
0.32
5.72
1.2
1.5
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
615
5225
1.29
5.48
3.0
2.6
ug/l
113.0
121.6
0.51
596
4771
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
16
489
0.32
5.41
5.1
4.9
%
1.7
1.5
0.30
16
459
(3049717) Cytology report of Urine Cyto stain
78
448
1.78
5.31
2.5
2.6
—
—
—
0
0
(4133840)
11
22
5.03
5.26
1.3
1.1
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
6
268
0.22
5.22
9.7
7.0
mmol/l
106.5
105.1
—
6
240
(3039000) Anion gap in Blood
6
268
0.22
5.22
9.7
6.9
mmol/l
11.3
11.0
—
6
240
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
804
7128
1.26
4.85
6.9
6.1
umol/l
11.6
10.9
0.83
779
6735
(3017143) Hepatitis C virus Ab [Presence] in Serum
154
1072
1.48
4.83
1.5
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
162
1143
1.46
4.75
1.8
1.7
%
1.5
1.4
0.15
112
996
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
22
540
0.40
4.70
3.6
3.3
%
47.4
47.7
0.02
22
532
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
790
7012
1.25
4.63
6.3
5.9
mmol/l
1.2
1.2
0.80
737
5896
(3025159) Blasts/100 leukocytes in Blood
60
1031
0.57
4.58
4.9
4.0
%
0.0
0.4
—
5
233
(3034426) Prothrombin time (PT)
13
34
3.85
4.54
1.0
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
25
99
2.55
4.47
1.9
2.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
108
709
1.56
4.46
1.2
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
24
94
2.58
4.39
1.7
1.6
%
10.2
10.5
0.18
24
94
(3025941) Bacteria identified in Stool by Culture
93
598
1.59
4.21
1.3
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
66
1073
0.60
4.10
3.8
4.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
203
1533
1.37
4.07
1.4
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
350
2859
1.29
4.06
1.7
1.8
mg/l
1.0
1.2
0.83
277
2230
(3020891) Body temperature
22
506
0.43
4.05
2.6
3.8
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
163
1187
1.42
4.05
8.3
7.4
g/l
121.1
119.6
0.43
163
1144
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1382
13203
1.34
3.93
18.6
13.4
mg/l
25.2
22.9
1.68
1139
10346
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
124
863
1.47
3.93
3.7
3.0
pmol/l
4.3
4.4
0.26
117
755
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
154
1118
1.42
3.90
1.4
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
37
697
0.52
3.90
2.9
3.4
mmol/l
4.7
2.1
2.49
30
549
(40759836) Histone Ab [Presence] in Serum by Immunoblot
24
100
2.42
3.90
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
24
100
2.42
3.90
1.2
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
40
732
0.53
3.84
3.1
3.4
ph
7.4
7.4
—
6
91
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
692
6138
1.22
3.83
3.3
3.8
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
189
1425
1.37
3.83
7.8
6.7
mmol/l
0.1
1.3
3.54
165
1136
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
24
101
2.40
3.82
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
24
101
2.40
3.82
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
24
101
2.40
3.82
1.2
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
24
101
2.40
3.82
1.2
1.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
482
4116
1.24
3.82
2.2
2.1
u/l
146.1
194.7
1.32
473
3848
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
34
168
2.05
3.71
1.1
1.1
u/ml
8.1
3.2
0.44
19
63
(3019060) Gas panel - Arterial blood
48
823
0.57
3.68
3.0
4.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
27
122
2.23
3.68
1.4
1.3
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
18
429
0.41
3.65
2.6
3.1
mmol/l
1.3
1.3
0.14
18
423
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
109
753
1.48
3.60
2.7
2.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
849
7718
1.21
3.58
4.9
4.1
mmol/l
6.6
6.7
0.15
819
7241
(4281824)
40
213
1.90
3.56
1.1
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
30
145
2.09
3.48
1.2
1.0
u/ml
2.8
4.0
—
10
60
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
170
1283
1.36
3.44
2.4
2.1
g/l
0.2
0.2
0.46
165
1209
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
303
2479
1.27
3.44
1.3
1.3
iu/ml
24.2
35.4
1.48
66
826
(3042936) Bacteria identified in Isolate by Culture
233
1843
1.31
3.43
2.1
1.9
—
—
—
0
0
(4268621)
26
120
2.19
3.39
2.1
2.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
13
42
3.11
3.37
3.2
2.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
18
71
2.55
3.30
5.4
3.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
381
3219
1.24
3.27
2.5
2.1
mg/l
3.2
3.1
0.14
331
2713
(3012441) Differential panel - Pleural fluid
26
122
2.15
3.27
1.8
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
24
109
2.22
3.26
1.2
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
31
156
2.01
3.26
1.2
1.1
u/ml
356.5
281.9
0.57
18
91
(1761482) Bacteria [#/volume] in Urine by Culture
15
366
0.40
3.25
2.7
4.5
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
7
11
6.39
3.18
1.0
1.0
—
—
—
0
0
(4306422)
31
158
1.98
3.15
1.1
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
27
132
2.06
3.07
2.5
2.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1129
10630
1.21
3.03
9.0
7.4
u/l
84.9
79.3
3.12
990
9929
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
31
161
1.94
3.00
1.0
1.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
184
1436
1.32
2.99
1.9
1.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
664
5969
1.19
2.97
2.3
2.2
nmol/l
80.6
80.3
0.10
572
5299
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
32
169
1.91
2.96
1.1
1.1
u/ml
1.1
1.8
—
9
44
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
122
895
1.39
2.96
1.2
1.2
iu/ml
265.7
137.8
0.75
23
334
(3043409) Potassium [Moles/volume] in Arterial blood
17
377
0.45
2.93
2.6
3.3
mmol/l
3.7
3.8
0.62
17
360
(3020630) Protein [Mass/volume] in Serum or Plasma
145
1096
1.36
2.93
3.5
2.8
g/l
65.9
66.6
0.71
126
991
(3007566) Smooth muscle Ab [Titer] in Serum
56
351
1.62
2.90
1.5
1.1
titre
283.3
75.2
—
6
23
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
16
64
2.52
2.87
1.3
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
16
64
2.52
2.87
1.3
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
466
4067
1.21
2.86
3.5
3.0
mg/l
183.8
327.1
0.43
320
2316
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
24
466
0.51
2.85
2.8
3.7
mmol/l
27.2
25.3
1.73
24
434
(3021788) Differential panel - Synovial fluid
42
245
1.73
2.85
1.8
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
30
542
0.54
2.83
2.9
3.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
174
0.29
2.83
1.0
1.2
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
25
123
2.05
2.82
1.8
1.3
e6/l
10770.5
121884.5
1.06
15
69
(3017732) Neutrophils [#/volume] in Blood
58
885
0.64
2.82
2.4
2.9
e9/l
4.2
3.9
0.55
46
671
(3036603) Volume of Urine
20
90
2.24
2.80
1.5
1.4
—
1930.5
—
0
18
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
14
53
2.66
2.79
1.1
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
206
0.34
2.79
1.0
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
383
4418
0.83
2.74
2.4
3.0
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
11
283
0.38
2.74
3.0
2.7
mmol/l
2.0
1.5
0.31
11
276
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
31
167
1.87
2.72
1.2
1.2
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
10
267
0.37
2.70
3.2
2.8
mmol/l
9.8
7.5
—
10
261
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
34
190
1.81
2.67
1.7
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
26
133
1.97
2.66
1.5
1.6
—
—
—
0
0
(4034850)
67
449
1.51
2.63
6.0
9.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
283
2371
1.24
2.60
1.2
1.3
u/ml
18.0
10.8
0.45
59
889
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1379
13314
1.26
2.58
4.9
4.6
mmol/l
4.8
4.8
0.59
1345
12179
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
162
0.31
2.56
2.4
2.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
104
1392
0.73
2.51
2.7
3.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
241
2881
0.81
2.43
3.2
4.2
kg/l
1.0
1.0
0.00
23
438
(3022217) INR in Platelet poor plasma by Coagulation assay
209
1706
1.26
2.42
40.5
24.6
inr
1.4
1.3
—
6
227
(3032773) Endomysium IgG Ab [Titer] in Serum
21
103
2.05
2.42
1.0
1.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
30
167
1.81
2.41
1.1
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
16
70
2.30
2.41
1.5
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
64
434
1.49
2.40
1.7
1.6
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
15
64
2.36
2.39
1.9
2.5
u/ml
637.7
1178.9
1.24
15
64
(3016018) Differential panel - Cerebral spinal fluid
24
125
1.93
2.36
1.5
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
23
118
1.96
2.36
1.9
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
57
379
1.52
2.35
1.5
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
221
1825
1.24
2.32
1.4
1.3
titre
456.7
618.6
0.66
48
402
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
47
301
1.58
2.29
1.1
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
27
148
1.84
2.29
1.8
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
297
2534
1.21
2.28
1.5
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
58
390
1.51
2.28
1.5
1.4
ug/g
245.9
279.6
0.61
37
220
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
170
0.35
2.28
1.2
1.5
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
13
53
2.46
2.28
1.0
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
589
5334
1.16
2.26
7.5
8.7
inr
1.4
1.2
1.15
105
1486
(3051593) INR in Capillary blood by Coagulation assay
0
60
0.00
2.24
0.0
12.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
52
344
1.53
2.21
2.0
1.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
883
8252
1.16
2.20
3.0
3.0
u/l
52.7
48.4
0.43
859
7563
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1302
12544
1.20
2.20
5.6
5.1
mu/l
1.9
2.3
1.51
1248
11348
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
369
4192
0.84
2.16
2.4
2.3
u/l
56.7
58.6
0.50
352
3827
(3028026) IgM [Mass/volume] in Serum or Plasma
99
743
1.35
2.16
2.4
1.8
g/l
1.5
1.4
0.04
89
670
(3021447) Carbon dioxide [Partial pressure] in Venous blood
137
1078
1.30
2.15
4.2
3.0
kpa
6.0
5.8
0.97
129
1046
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
7
19
3.70
2.15
1.4
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
14
61
2.31
2.15
2.6
1.5
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
17
81
2.11
2.13
1.1
1.3
u/l
10.8
10.3
0.06
17
71
(21491868) Cryoglobulin [Mass/volume] in Serum
13
55
2.37
2.12
1.1
1.2
g/l
—
0.4
—
0
7
(3038177) Helicobacter pylori Ab [Presence] in Serum
31
183
1.71
2.08
1.4
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1398
13581
1.23
2.06
5.9
5.2
mmol/l
2.8
2.8
0.18
1365
12361
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
7
20
3.51
2.05
1.0
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
119
926
1.31
2.04
3.6
2.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
170
1386
1.25
2.02
2.0
2.5
%
1.7
1.8
1.02
159
1246
(3020779) Urea [Moles/volume] in Serum or Plasma
129
1023
1.28
1.93
7.3
6.2
mmol/l
9.7
9.4
0.20
122
967
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1361
13205
1.20
1.92
4.5
4.6
mmol/l
1.5
1.6
5.95
1325
11997
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
51
0.00
1.88
0.0
1.6
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
51
0.00
1.88
0.0
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
51
0.00
1.88
0.0
1.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
133
1064
1.27
1.86
4.3
3.0
mmol/l
2.1
2.1
0.00
113
884
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
217
1833
1.21
1.86
1.3
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
39
253
1.56
1.85
1.4
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
26
152
1.72
1.84
1.3
1.2
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
25
145
1.74
1.82
1.9
1.3
e6/l
622.1
2652.0
1.46
15
101
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
181
0.44
1.81
1.3
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
189
1579
1.22
1.81
3.9
4.1
ug/l
5.1
28.4
1.97
144
1292
(44816559) Phosphatidylethanol [Mass/volume] in Blood
29
176
1.66
1.80
1.3
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
150
0.40
1.77
2.8
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
152
0.39
1.76
2.8
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
14
67
2.10
1.76
1.4
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
16
297
0.53
1.75
1.9
1.8
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
53
742
0.70
1.75
2.3
2.6
g/l
124.9
127.1
0.32
53
723
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
25
147
1.71
1.74
1.1
1.1
u/ml
0.2
1.0
—
7
56
(3036782) Glucose [Moles/volume] in Pleural fluid
20
110
1.83
1.73
1.6
1.4
mmol/l
5.8
6.5
0.62
20
102
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
40
266
1.52
1.72
1.6
1.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
28
171
1.65
1.71
1.7
1.3
pmol/l
258.6
281.5
0.21
19
138
(3035637) Corticotropin [Mass/volume] in Plasma
23
133
1.74
1.70
1.8
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
28
441
0.63
1.67
1.7
1.8
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
6
19
3.17
1.66
1.0
1.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
31
476
0.64
1.65
1.2
1.4
—
—
—
0
0
(3012501) Base excess in Blood by calculation
15
278
0.54
1.65
3.1
3.4
mmol/l
4.5
2.8
—
8
204
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
146
0.41
1.64
2.5
1.3
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
22
127
1.74
1.64
1.0
1.1
u/ml
3.5
1.5
—
9
57
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
149
0.40
1.63
2.8
1.3
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
14
3.58
1.61
1.0
1.3
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
5
14
3.58
1.61
1.0
1.3
%
92.6
101.6
—
5
14
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
86
664
1.31
1.61
1.5
1.4
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
134
0.37
1.61
1.6
2.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
15
77
1.96
1.59
1.1
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
6
20
3.01
1.58
1.0
1.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1294
12552
1.16
1.58
7.1
5.8
mmol/mol
40.5
39.8
1.97
1261
11469
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
429
3886
1.14
1.56
1.5
1.6
mmol/l
1.4
1.4
0.01
396
3235
(3000494) Fungus identified in Specimen by Culture
189
1605
1.20
1.56
1.4
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
21
122
1.73
1.55
1.4
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
18
100
1.81
1.53
1.4
1.3
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
43
0.00
1.52
0.0
1.4
—
25.1
—
0
30
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
144
0.41
1.51
2.5
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
144
0.41
1.51
2.5
1.3
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1431
14005
1.20
1.51
21.2
15.7
mmol/l
3.9
4.0
6.37
1423
13603
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
44
0.00
1.51
0.0
1.1
—
1702.6
—
0
44
(3027944) Amphetamines [Presence] in Urine
22
131
1.69
1.49
1.4
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
67
506
1.34
1.48
1.8
1.6
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
21
124
1.70
1.47
1.0
1.1
u/ml
0.6
1.8
—
7
50
(3027008) Opiates [Presence] in Urine
22
132
1.68
1.46
1.4
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
22
132
1.68
1.46
1.4
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
39
269
1.46
1.45
2.0
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
23
364
0.63
1.43
1.5
1.3
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
6
22
2.73
1.43
4.7
4.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
22
2.73
1.43
1.0
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
43
303
1.43
1.43
1.4
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
27
172
1.58
1.43
1.2
1.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
36
245
1.48
1.43
3.2
2.6
umol/l
34.2
36.4
0.25
30
210
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
29
189
1.54
1.40
1.3
1.3
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
9
40
2.26
1.40
1.2
1.1
iu/ml
173.7
196.4
—
9
40
(3033799) Differential panel - Peritoneal fluid
10
46
2.18
1.40
1.9
1.8
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
354
3190
1.14
1.39
1.7
1.5
nmol/l
20.6
21.5
0.64
326
2671
(3028300) Cannabinoids [Presence] in Urine
22
134
1.65
1.39
1.4
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1445
14172
1.20
1.38
13.4
10.7
u/l
25.2
24.4
1.21
1433
13607
(40767503) Oxygen content in Capillary blood by calculation
14
248
0.56
1.36
3.6
2.4
%
17.3
16.1
—
8
123
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
17
2.95
1.36
1.0
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
128
1063
1.22
1.35
3.8
3.1
ug/l
0.7
0.8
0.39
94
728
(3044941) Cell count panel - Synovial fluid
33
224
1.48
1.34
1.8
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
14
76
1.85
1.30
1.8
1.8
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1424
13964
1.18
1.27
20.6
15.5
mmol/l
139.8
139.8
0.55
1416
13579
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
8
159
0.50
1.25
1.1
1.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
8
36
2.23
1.24
1.0
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
27
179
1.52
1.24
1.1
1.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
15
252
0.59
1.22
3.7
3.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
27
180
1.51
1.21
1.3
1.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
78
622
1.27
1.20
1.1
1.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
453
4181
1.12
1.20
3.1
3.0
mmol/l
6.5
6.7
0.47
257
3483
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
15
250
0.60
1.19
2.0
1.3
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
114
951
1.21
1.18
3.3
2.7
g/l
10.3
10.4
0.12
105
858
(3051611) Lipemic interference index of Serum or Plasma
22
142
1.56
1.14
5.1
3.0
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
0
36
0.00
1.14
0.0
1.5
—
50.5
—
0
30
(3019230) Fractional oxyhemoglobin in Venous blood
30
208
1.45
1.13
2.1
1.9
%
62.0
61.4
0.06
30
208
(3042631) Mycobacterium sp identified in Specimen
10
183
0.54
1.12
2.2
2.6
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
11
58
1.90
1.12
1.0
1.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
533
4980
1.11
1.11
4.4
3.4
mmol/l
2.4
2.4
2.03
502
4306
(3006184) Hemoglobin [Mass/volume] in Capillary blood
17
268
0.63
1.09
2.6
2.2
g/l
137.2
127.7
1.16
11
193
(3006922) Hepatitis E virus Ab [Presence] in Serum
12
66
1.82
1.09
1.2
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
12
206
0.58
1.08
3.7
2.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
33
236
1.41
1.07
1.2
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1305
12756
1.12
1.06
4.2
4.1
mmol/l
1.3
1.3
2.07
1272
11480
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
20
129
1.56
1.05
1.2
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
7
33
2.13
1.05
1.1
1.4
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
9
46
1.96
1.03
2.9
1.8
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
11
60
1.84
1.03
1.9
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1355
13286
1.13
1.00
5.2
4.8
mmol/l
6.1
5.9
3.27
1319
11993
(40768441) Liver Pathology biopsy report
17
107
1.60
0.99
1.3
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
110
933
1.19
0.99
1.2
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
69
558
1.25
0.98
2.6
2.0
u/l
44.0
39.4
1.26
62
489
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
11
61
1.81
0.98
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
61
1.81
0.98
1.1
1.0
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
0
29
0.00
0.97
0.0
1.1
—
216.0
—
0
5
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
32
0.00
0.95
0.0
2.7
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
52
410
1.28
0.92
5.8
3.6
mg/l
35.0
72.5
1.34
44
340
(3021601) Nitrite [Presence] in Urine by Test strip
690
6573
1.09
0.92
4.9
5.2
estimate
0.0
0.0
0.50
79
1152
(3007461) Platelets [#/volume] in Blood
1475
14558
1.17
0.91
25.9
20.4
e9/l
257.4
255.8
0.37
1419
14150
(3024932) HLA-DR beta [Type]
6
28
2.15
0.91
1.0
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
33
244
1.36
0.91
1.4
1.2
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
52
411
1.27
0.91
5.8
3.6
mg/l
20.0
58.1
1.84
44
343
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
45
574
0.78
0.90
2.0
2.3
%
1.4
1.2
0.66
45
569
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
6
29
2.07
0.89
1.2
1.4
—
—
—
0
0
(3024471) HLA-A [Type]
6
29
2.07
0.89
1.0
1.0
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
17
111
1.54
0.87
1.8
1.8
nmol/l
44.0
43.0
0.07
17
105
(3026361) Erythrocytes [#/volume] in Blood
1475
14564
1.16
0.87
25.9
20.4
e12/l
4.4
4.4
2.50
1458
14103
(3010813) Leukocytes [#/volume] in Blood
1475
14565
1.16
0.87
26.0
20.4
e9/l
6.7
6.5
0.84
1457
14101
(3023511) Choriogonadotropin [Units/volume] in Urine
6
30
2.00
0.87
1.2
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
34
255
1.34
0.87
2.0
2.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
18
264
0.68
0.87
4.5
3.4
%
57.3
57.9
0.09
18
264
(3001964) Herpes simplex virus Ag [Presence] in Specimen
8
44
1.82
0.86
1.3
1.2
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1475
14569
1.16
0.84
26.1
20.5
g/l
132.9
132.9
0.06
1470
14324
(3037121) Protein [Mass/volume] in Urine
33
433
0.76
0.83
2.4
2.8
g/l
0.4
0.3
0.25
22
155
(3045142) Bone marrow Pathology biopsy report
24
171
1.41
0.83
1.1
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
17
113
1.51
0.82
1.2
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
19
270
0.70
0.79
2.3
2.5
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
0
24
0.00
0.79
0.0
1.2
—
2.1
—
0
14
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
24
0.00
0.79
0.0
6.6
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
26
0.00
0.78
0.0
6.7
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
26
0.00
0.78
0.0
1.7
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
27
0.00
0.77
0.0
1.4
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
6
34
1.77
0.76
1.2
1.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
64
765
0.83
0.75
1.1
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
70
589
1.20
0.73
1.6
1.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
690
6622
1.07
0.73
3.7
3.8
estimate
0.0
0.0
0.31
76
1138
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
53
434
1.23
0.72
1.8
1.8
mg/l
14.6
2.5
0.47
32
327
(4010399)
111
972
1.15
0.72
1.6
1.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
7
39
1.80
0.72
1.7
1.5
ug/l
10.0
9.3
—
7
39
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
68
1.62
0.71
1.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
13
194
0.67
0.71
1.2
1.3
nmol/l
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
130
1155
1.14
0.70
2.0
2.1
nmol/l
359.3
380.0
0.61
121
1038
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
143
0.63
0.69
1.1
1.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
14
204
0.68
0.68
1.4
1.3
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
28
1.79
0.66
2.2
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
28
1.79
0.66
1.2
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
92
1047
0.87
0.62
2.1
2.5
e9/l
68.3
70.9
0.19
49
790
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
8
49
1.64
0.62
1.0
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
21
279
0.75
0.62
1.1
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1041
10169
1.07
0.61
4.1
4.1
mm/h
13.9
13.2
0.88
1015
9348
(3009871) Measles virus Ab [Titer] in Serum
5
30
1.67
0.61
1.8
1.9
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
452
4300
1.07
0.60
3.9
3.8
mg/mmol
12.6
7.3
1.32
191
2492
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
29
227
1.28
0.60
1.1
1.3
mmol/l
67.8
59.6
0.40
23
178
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
21
0.00
0.60
0.0
7.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1054
10770
0.94
0.59
4.0
4.3
pmol/l
14.4
14.9
13.52
996
9723
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
16
114
1.41
0.59
1.1
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
30
237
1.27
0.58
1.2
1.5
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
6
35
1.72
0.57
1.2
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
17
230
0.74
0.57
1.8
1.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
90
0.55
0.55
1.2
1.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
673
6503
1.06
0.55
3.4
3.8
estimate
0.0
0.0
0.00
75
1145
(3000475) Leukocytes [#/volume] in Synovial fluid
40
330
1.22
0.55
1.9
1.7
e6/l
6596.6
11875.8
1.21
28
242
(3024263) Appearance of Synovial fluid
10
66
1.52
0.52
1.8
1.8
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
14
100
1.40
0.52
1.2
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
135
0.66
0.51
1.1
1.5
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
6
40
1.50
0.51
1.5
1.5
ug/l
0.5
0.5
—
6
24
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
214
0.75
0.51
1.1
1.4
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
46
389
1.19
0.50
1.7
1.7
g/l
0.2
0.2
0.05
41
370
(3027135) IgG subclass 1 [Mass/volume] in Serum
16
118
1.36
0.50
1.4
1.6
g/l
8.0
7.5
0.17
16
84
(3028192) IgG subclass 2 [Mass/volume] in Serum
16
118
1.36
0.50
1.4
1.6
g/l
2.6
2.8
0.32
16
84
(3010375) cycloSPORINE [Mass/volume] in Blood
6
41
1.47
0.50
30.7
27.6
ug/l
128.0
105.0
—
6
33
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
22
279
0.79
0.49
1.2
1.5
—
—
—
0
0
(1002224) Polysomnography panel
38
453
0.83
0.48
1.0
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
14
102
1.38
0.47
1.0
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
41
346
1.19
0.47
2.2
1.8
iu/l
4.0
5.1
0.32
19
104
(3044927) Protein electrophoresis panel - Urine
10
142
0.70
0.46
1.2
1.2
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
48
412
1.17
0.46
1.2
1.7
—
340.9
—
0
22
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
84
0.59
0.45
1.0
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
71
629
1.13
0.45
1.2
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
8
58
1.38
0.41
1.1
1.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
15
0.00
0.41
0.0
4.1
—
—
—
0
0
(44806071)
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
20
159
1.26
0.40
1.5
1.2
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
0
18
0.00
0.40
0.0
1.1
—
1.6
—
0
11
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.1
—
50.2
—
0
6
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
18
0.00
0.40
0.0
1.3
—
1.6
—
0
18
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
32
269
1.19
0.39
1.5
1.2
e6/l
26.2
27.9
0.02
26
205
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
8
61
1.31
0.39
1.5
1.1
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
5
35
1.43
0.39
2.0
2.0
%
14.2
26.7
—
5
30
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(44790048)
17
133
1.28
0.38
1.1
1.3
—
—
—
0
0
(44790049)
17
133
1.28
0.38
1.1
1.3
—
—
—
0
0
(44806118)
17
133
1.28
0.38
1.1
1.3
—
—
—
0
0
(44790047)
17
133
1.28
0.38
1.1
1.3
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
32
270
1.19
0.38
1.5
1.3
e6/l
369.8
700.8
0.40
26
221
(4035726)
146
1359
1.08
0.38
1.3
1.4
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
5
36
1.39
0.38
2.0
2.0
%
9.8
10.0
—
5
31
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
17
214
0.79
0.38
1.1
1.6
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
10
135
0.74
0.36
1.2
1.2
mosm/kgh2o
289.4
275.0
—
5
98
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
21
171
1.23
0.35
1.0
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
168
0.77
0.35
1.2
1.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
30
352
0.85
0.35
1.4
1.6
iu/ml
4.0
0.1
—
10
65
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
10
73
1.37
0.34
1.0
1.1
u/l
1.0
1.1
—
5
45
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
412
3983
1.05
0.33
2.3
2.9
ng/l
1276.9
1220.0
0.11
311
3393
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
6
87
0.69
0.33
1.2
1.4
—
1.5
—
0
6
(40760888) Immunoglobulin light chains.free panel - Serum
35
303
1.16
0.33
5.3
3.9
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
100
926
1.09
0.31
1.9
1.8
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
36
411
0.87
0.31
1.1
1.3
—
30.3
—
0
30
(3037756) Immunofixation for Serum or Plasma
25
293
0.85
0.30
1.4
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
12
93
1.29
0.30
1.2
1.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1376
13656
1.05
0.29
12.4
12.8
—
—
—
0
0
(4062490)
15
121
1.24
0.28
1.4
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
13
162
0.80
0.28
1.2
1.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
10
129
0.77
0.28
1.1
1.1
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
12
94
1.28
0.28
2.3
2.0
ug/l
7.6
3.2
0.54
12
87
(3002523) Influenza virus A Ag [Presence] in Specimen
10
128
0.78
0.27
1.1
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
36
405
0.89
0.26
1.7
2.6
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
36
320
1.13
0.25
1.2
1.1
u/ml
2.2
6.6
—
5
36
(3006442) Creatine [Moles/volume] in Serum or Plasma
9
74
1.22
0.25
1.7
1.7
—
64.3
—
0
7
(1617658) Protocol used for examination of sentinel lymph nodes
15
180
0.83
0.24
1.1
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
82
0.73
0.24
2.0
1.9
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
5
39
1.28
0.23
1.0
1.1
pmol/l
225.6
217.8
—
5
26
(3008898) HLA-B27 [Presence]
41
371
1.11
0.22
1.0
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
95
0.74
0.22
1.0
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
263
2546
1.04
0.22
1.9
1.7
nmol/l
874.6
1204.3
7.18
208
1879
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
12
0.00
0.21
0.0
1.9
—
—
—
0
0
(3001729) Color of Synovial fluid
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
2.3
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
12
98
1.23
0.21
1.1
1.5
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
43
1.16
0.21
1.2
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
11
89
1.24
0.21
1.1
1.2
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
137
1309
1.05
0.20
1.6
1.5
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
13.2
—
0
14
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
9
114
0.79
0.20
1.0
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
19
165
1.15
0.19
1.1
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
14
118
1.19
0.19
1.8
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
15
128
1.17
0.18
1.1
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
10
82
1.22
0.17
2.5
1.9
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
5
68
0.73
0.17
1.6
1.3
%
—
5.6
—
0
15
(3006653) Thiamine [Moles/volume] in Blood
5
69
0.72
0.17
1.0
1.2
nmol/l
165.8
132.8
—
5
69
(3017704) Immunofixation for Urine
5
70
0.71
0.16
1.0
1.8
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
8
69
1.16
0.16
1.0
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
70
1.14
0.16
1.0
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
18
204
0.88
0.16
1.2
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
8
71
1.13
0.16
1.1
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
11
92
1.20
0.16
2.2
2.3
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
7
88
0.79
0.14
1.1
1.1
mg/l
38.8
39.5
—
7
78
(1175426) CD3 cells/100 lymphocytes in Blood
7
88
0.79
0.14
1.9
1.9
%
58.4
71.9
—
7
83
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
8
96
0.83
0.13
1.1
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
9
106
0.85
0.13
1.2
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
14
123
1.14
0.12
1.0
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
39
365
1.07
0.12
1.6
1.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
114
1107
1.03
0.10
2.1
2.2
ug/l
8.0
6.4
0.39
102
957
(3023419) Bacteria identified in Sputum by Culture
14
156
0.90
0.10
1.2
2.4
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
10
113
0.88
0.08
1.1
1.1
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
17
185
0.92
0.08
1.1
1.3
—
47.1
—
0
12
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
179
1821
0.98
0.07
5.5
5.1
ug/l
4.2
3.0
0.27
162
1605
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
7
81
0.86
0.07
1.0
1.1
mg/l
369.7
255.0
—
7
74
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
94
0.85
0.06
1.0
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
143
1456
0.98
0.06
5.0
4.5
%
23.2
21.2
0.56
60
723
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
9
101
0.89
0.06
8.1
5.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
27
256
1.06
0.06
1.4
1.2
miu/ml
136.9
232.7
0.88
16
113
(3017446) Testosterone [Moles/volume] in Serum or Plasma
37
355
1.04
0.06
2.4
2.1
nmol/l
11.8
12.1
0.09
30
307
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
60
584
1.03
0.05
1.5
1.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
110
1.09
0.05
1.0
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
55
536
1.03
0.04
1.2
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
78
795
0.98
0.04
1.5
1.4
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
80
786
1.02
0.03
1.1
1.2
u/ml
231.5
162.7
0.25
75
719
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
110
1115
0.99
0.03
1.8
2.5
ml/min/173m2
54.1
63.8
1.70
35
445
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
15
159
0.94
0.03
1.3
1.2
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
10
92
1.09
0.03
1.2
1.8
—
42.2
—
0
9
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
41
402
1.02
0.01
1.1
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
36
353
1.02
0.01
1.5
1.6
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
29
284
1.02
0.00
1.1
1.2
mmol/l
3.9
3.7
0.42
29
275
(3024354) Oxygen [Partial pressure] in Venous blood
89
894
1.00
0.00
2.6
2.5
kpa
4.6
4.4
0.40
79
865
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
30
298
1.01
0.00
1.2
1.5
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
32
315
1.02
0.00
1.3
1.2
mg/l
632.3
521.9
0.65
32
305
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4027681)
6
63
0.95
0.00
1.0
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
73
0.96
0.00
1.1
1.1
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.7
—
205.5
—
0
6
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.0
—
36.2
—
0
9
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
6
62
0.97
0.00
1.2
1.3
mmol/l
6.1
6.2
—
6
57
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
51
0.98
0.00
1.0
1.2
—
—
—
0
0
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.0
—
21.8
—
0
9
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
9
89
1.01
0.00
1.2
1.6
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.4
—
0.1
—
0
5
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
2.5
—
0
6
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042301) Urate [Moles/volume] in Synovial fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.0
—
9.1
—
0
9
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
57
0.88
0.00
1.4
1.0
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
6
62
0.97
0.00
1.8
2.8
—
43.7
—
0
16
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_CHOLERA and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have AB1_CHOLERA.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

↥

Index endpoint: AB1_CHOLERA – Cholera

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data